GRFS
Grifols, S.A.
NasdaqGS
People also watch:SHPGIRWDAKRXGEVAPCRX
17.020.07 (0.39%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close16.95
Open17.10
Bid17.00 x 900
Ask17.01 x 1600
52wk Range14.07 - 18.04
Day's Range16.98 - 17.12
Volume835,992
Avg Vol (3m)1,242,765
As of 2:32 PM EDT. NasdaqGS Real Time Price. Market open.
  • Capital Cube1 hour ago

    ETF’s with exposure to Grifols SA : July 25, 2016

    Click here to see latest analysisETF’s with exposure to Grifols SAHere are 5 ETF’s with the largest exposure to GRFS-US. Comparing the performance and risk of Grifols SA with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility.TickerFund NameGRFS-US Exposure (%)1 Year Price […] (Read more...) The post ETF’s with exposure to Grifols SA : July 25, 2016 appeared first on CapitalCube.

  • Grifols SA : GRFS-US: Dividend Analysis : June 06th, 2016 (record date) : By the numbers : July 12, 2016
    Capital Cube13 days ago

    Grifols SA : GRFS-US: Dividend Analysis : June 06th, 2016 (record date) : By the numbers : July 12, 2016

    Click here to see latest analysisOur analysis is based on comparing Grifols SA with the following peers – Baxter International Inc., China Biologic Products, Inc., Amgen Inc., China Cord Blood Corporation, Kimberly-Clark Corporation, Johnson & Johnson, Cord Blood America, Inc., Aradigm Corporation and Mylan N.V. (BAX-US, CBPO-US, AMGN-US, CO-US, KMB-US, JNJ-US, CBAI-US, ARDM-US and MYL-US).Grifols […] (Read more...) The post Grifols SA : GRFS-US: Dividend Analysis : June 06th, 2016 (record date) : By the numbers : July 12, 2016 appeared first on CapitalCube.